GlassScriptPhysician profile
Angela M Sutton
NPI 1124361159
$10,284.38
in general payments reported to CMS, 2019-2025
40 companies · $2,026 in 2025
The $2,026 reported for 2025 was more than what 76% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,354 · 2020: $520 · 2021: $401 · 2022: $1,134 · 2023: $3,002 · 2024: $1,848 · 2025: $2,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,661 · Education: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,661.13 |
| Education | $214.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,448.53 | 2019-2025 | Rinvoq, Skyrizi |
| Regeneron Healthcare Solutions, INC. | $988.25 | 2019-2025 | Libtayo, Dupixent |
| Amgen INC. | $968.62 | 2019-2025 | Otezla, Otezla |
| Lilly USA, LLC | $777.15 | 2020-2025 | Taltz, Ebglyss, Olumiant |
| Novartis Pharmaceuticals Corporation | $713.51 | 2019-2025 | |
| Janssen Biotech, INC. | $666.72 | 2019-2025 | Tremfya, Simponi Aria, Simponi |
| Dermavant Sciences, INC. | $601.16 | 2022-2024 | Vtama |
| Incyte Corporation | $552.96 | 2021-2025 | Opzelura |
| Ucb, INC. | $402.16 | 2019-2025 | Bimzelx, Cimzia |
| Arcutis Biotherapeutics, INC. | $367.16 | 2023-2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $289.80 | 2019-2025 | Winlevi, Ilumya |
| Pfizer INC. | $284.73 | 2019-2025 | |
| Leo Pharma INC. | $284.39 | 2019-2025 | Adbry, Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $276.30 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $247.21 | 2019-2024 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.